Adverse events

N = 36

Patients presenting at least one AE, n %

95% CI (exact)

36 (100%)

(90.3%; 100.0%)

The total number of AEs reported in the study

290

Days between the start of the trial and adverse events

Mean (SD)

30 (20.8)

Median (IQR)

28 (11.7-46.3)

Min, Max

0; 103